First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID-19 in an allogeneic stem cell transplant patient.
Nicholas J FordhamEmma BakerDaniel FortonMatthias KlammerKamal PatelDara QadirYasmin ReyalFenella WillisMickey B C KohPublished in: EJHaem (2020)